...screening of oncogenes, tumor suppressor gene TP53 and 555 nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors. BMC. Cancer 15 556 157. 557 Flint A & Lloyd RV 1990 Hurthle-cell neoplasms of the thyroid gland. Pathol Annu 25 Pt 1 37-558 52. 559 Ganly I, Ricarte FJ, Eng S, Ghosse ~~~

...screening for phaeochromotycoma using 195 urinary or plasma metanephrines and normetanephrines and MIBG scanning are particularly useful 196 for early detection of these tumours in MEN2 patients, enabling timely intervention with lower 197 associated morbidities (Därr et al 2012). For instance, the ~~~

...screening approach is required in order to detect NENs as early as possible, thus obtaining a 395 reduction in MEN-1 related morbidity and mortality (Pieterman et al. 2009; Ramundo et al. 2011). 396 To date, the standard of care suggest annual CgA determination, but this statement is defined as 397 ~~~

...screening strategies based on 36 quantitative factors could help avoid unnecessary biopsies. Here, we sought 37 to clarify the predictive value of free testosterone (FT) versus total 38 testosterone (TT) in identifying patients likely to have positive biopsies. This 39 study aims to develop a novel ~~~

...screening and fine-needle aspiration (FNA) strongly correlate with the 56 observed increase in incidence (Burgess and Tucker, 2006, Ahn et al., 2014). Our recent 57 investigation has also found that the increasing incidence of DTC is not mirrored by the 58 prevalence of incidental DTC in autopsy stu ~~~